Boston Scientific Statistics
Total Valuation
BSX has a market cap or net worth of $84.88 billion. The enterprise value is $96.87 billion.
Important Dates
The last earnings date was Wednesday, April 22, 2026, before market open.
| Earnings Date | Apr 22, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BSX has 1.49 billion shares outstanding. The number of shares has increased by 0.42% in one year.
| Current Share Class | 1.49B |
| Shares Outstanding | 1.49B |
| Shares Change (YoY) | +0.42% |
| Shares Change (QoQ) | -0.05% |
| Owned by Insiders (%) | 0.19% |
| Owned by Institutions (%) | 94.04% |
| Float | 1.48B |
Valuation Ratios
The trailing PE ratio is 24.46 and the forward PE ratio is 16.87. BSX's PEG ratio is 1.11.
| PE Ratio | 24.46 |
| Forward PE | 16.87 |
| PS Ratio | 4.21 |
| Forward PS | 3.81 |
| PB Ratio | 3.58 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | 1.11 |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 27.17 |
| EV / Sales | 4.70 |
| EV / EBITDA | 17.85 |
| EV / EBIT | 23.97 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.49 |
| Debt / EBITDA | 2.21 |
| Debt / FCF | n/a |
| Interest Coverage | 11.32 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 11.15% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 7.86% |
| Revenue Per Employee | $349,390 |
| Profits Per Employee | $60,424 |
| Employee Count | 59,000 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BSX has paid $184.00 million in taxes.
| Income Tax | 184.00M |
| Effective Tax Rate | 4.92% |
Stock Price Statistics
The stock price has decreased by -44.07% in the last 52 weeks. The beta is 0.78, so BSX's price volatility has been lower than the market average.
| Beta (5Y) | 0.78 |
| 52-Week Price Change | -44.07% |
| 50-Day Moving Average | 67.70 |
| 200-Day Moving Average | 90.46 |
| Relative Strength Index (RSI) | 33.96 |
| Average Volume (20 Days) | 16,499,104 |
Short Selling Information
The latest short interest is 25.61 million, so 1.72% of the outstanding shares have been sold short.
| Short Interest | 25.61M |
| Short Previous Month | 25.44M |
| Short % of Shares Out | 1.72% |
| Short % of Float | 1.73% |
| Short Ratio (days to cover) | 1.66 |
Income Statement
In the last 12 months, BSX had revenue of $20.61 billion and earned $3.57 billion in profits. Earnings per share was $2.39.
| Revenue | 20.61B |
| Gross Profit | 14.15B |
| Operating Income | 4.04B |
| Pretax Income | 3.74B |
| Net Income | 3.57B |
| EBITDA | 5.43B |
| EBIT | 4.04B |
| Earnings Per Share (EPS) | $2.39 |
Full Income StatementBalance Sheet
The company has $1.97 billion in cash and $11.97 billion in debt, giving a net cash position of -$10.01 billion or -$6.73 per share.
| Cash & Cash Equivalents | 1.97B |
| Total Debt | 11.97B |
| Net Cash | -10.01B |
| Net Cash Per Share | -$6.73 |
| Equity (Book Value) | 24.47B |
| Book Value Per Share | 16.34 |
| Working Capital | n/a |
Full Balance SheetCash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 1.39B |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
Gross margin is 68.63%, with operating and profit margins of 19.61% and 17.29%.
| Gross Margin | 68.63% |
| Operating Margin | 19.61% |
| Pretax Margin | 18.16% |
| Profit Margin | 17.29% |
| EBITDA Margin | 26.33% |
| EBIT Margin | 19.61% |
| FCF Margin | n/a |